Akebia Therapeutics
AKBA
AKBA
126 hedge funds and large institutions have $282M invested in Akebia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-13
Holders Change %
-9.35%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
49
Reduced
36
Closed
22
Calls
$1.52M
Puts
$1.8M
Net Calls
-$280K
Net Calls Change
+$1.19M
Top Buyers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$20.1M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$6.69M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$45.7M |
| 4 |
4
Prudential Financial
Newark,
New Jersey
|
$3.12M |
| 5 |
5
BlackRock
New York
|
$40.5M |
Top Sellers
| 1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$1.48M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$6.04M |
| 4 |
4
Morgan Stanley
New York
|
$4.24M |
| 5 |
5
Renaissance Technologies
New York
|
$2.74M |
